Abstract | OBJECTIVE: RESEARCH DESIGN AND METHODS: This study was a 6-month multinational open parallel-group comparison conducted at 46 centers in five countries and included 448 patients with type 1 diabetes randomized 2:1 to insulin detemir or NPH insulin, respectively. RESULTS: CONCLUSIONS:
|
Authors | Philippe Vague, Jean-Louis Selam, Svein Skeie, Ivo De Leeuw, Jan W F Elte, Hanne Haahr, Allan Kristensen, Eberhard Draeger |
Journal | Diabetes care
(Diabetes Care)
Vol. 26
Issue 3
Pg. 590-6
(Mar 2003)
ISSN: 0149-5992 [Print] United States |
PMID | 12610006
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Glucose
- Carrier Proteins
- Glycated Hemoglobin A
- Hypoglycemic Agents
- Insulin
- Insulin, Long-Acting
- Insulin Detemir
- Insulin, Isophane
- Insulin Aspart
|
Topics |
- Adult
- Blood Glucose
(metabolism)
- Body Weight
- Carrier Proteins
(administration & dosage, adverse effects)
- Diabetes Mellitus, Type 1
(blood, drug therapy)
- Eating
- Female
- Glycated Hemoglobin
(analysis)
- Humans
- Hypoglycemia
(chemically induced, epidemiology)
- Hypoglycemic Agents
(administration & dosage, adverse effects)
- Incidence
- Insulin
(administration & dosage, adverse effects, analogs & derivatives)
- Insulin Aspart
- Insulin Detemir
- Insulin, Isophane
(administration & dosage, adverse effects)
- Insulin, Long-Acting
- Male
- Middle Aged
- Risk Factors
|